Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients

Education Intervention on Vaccination Adherence Among IBD Patients at Weill Cornell Medical Center

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04672161

Enrollment

200

Registered

2020-12-17

Start date

2021-02-04

Completion date

2023-06-30

Last updated

2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease (CD), Indeterminate Colitis, Ulcerative Colitis (UC)

Keywords

Vaccine, HPV, Vaccination, IBD, Inflammatory Bowel Diseases, UC, CD

Brief summary

A retrospective chart review and a six-month prospective outcome analysis aimed to evaluate the efficacy of a vaccination education intervention and vaccination adherence among IBD patients at Weill-Cornell Medical Center. It is hypothesized that a general vaccination education campaign will improve vaccination adherence rates for all IBD patients. Secondarily, it is hypothesized that an Human Papilloma Virus (HPV) vaccination intervention targeted at high-risk IBD patients will increase vaccination adherence among these patients.

Interventions

OTHERVaccine Education

A baseline educational intervention on vaccination and its role in the health maintenance of patients with IBD will be provided to all participants. Those on immunosuppressive therapies and/or those age 65 or older will also be offered the pneumonia vaccine educational intervention. Finally, patients aged 18-26 and those 27-45 who have never been vaccinated for HPV or those with high risk for HPV will additionally receive the HPV educational intervention.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient at Weill-Cornell Medical Center with an in-person or virtual appointment between March 1 - August 30, 2021. * Documentation of an IBD diagnosis (CD, UC, IC).

Exclusion criteria

* No documentation of an IBD diagnosis. * Pregnant or breastfeeding. * No scheduled appointment between March 1-August 30, 2021.

Design outcomes

Primary

Measure	Time frame
Mean Change in Vaccination Adherence in Patients	Baseline; 6 months

Secondary

Measure	Time frame
Change in qualitative attitude assessment on vaccination adherence and non-adherence as measured by self-reported 6-month questionnaire.	Baseline; 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026